Global Life Sciences BPO Market

Global Life Sciences BPO Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Life science business process outsourcing (BPO) is one of the most lucrative industries in the
healthcare sector. Constantly rising pricing pressure and increasing competition is compelling
pharmaceutical and medical device companies to strategically reduce their operational costs and in
turn benefit from higher profits. This has led to an increasing demand for contract manufacturing
outsourcing (CMO) and contract research outsourcing (CRO) services. Asia and Latin America are
the most attractive markets for CMO and CRO, owing to low costs of production and research
activities performed here.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/24
Market Dynamics
The global life sciences BPO market is driven by factors such as increasing cost of research and
development (R&D), growing price pressures, and increase in investments by pharmaceutical
and medical devices companies in emerging economies such as India, China, Brazil, and South
Africa. Pharmaceutical and medical device companies are adopting inorganic growth strategies
to expand their business and reduce their Capital Expenditure (CAPEX) and Operation Costs
(OPEX). However, outsourcing certain services to different CMO and CRO companies located in
other countries is a challenge for the outsourcing company to monitor and follow a particular set
of guideline for product approval pertaining to regulatory filings, clinical trials and medical
writing. Collaborative efforts among various stakeholders of the ecosystem is analyzed to benefit
the life science BPO industry in the long run.
Patent expirations to boost the prospects for life sciences BPO market
According to UBM India Pharma Publication, over US$ 40 billion worth of drug are expected to be
off-patent in the U.S. by 2017. Also, in 2014, utilization of generic drugs resulted in savings of
around US$ 254 billion in the U.S. This trend is anticipated to increase further with more patent
expirations in the near future. This factor coupled with the advent of biosimilars is projected to
favor the growth of life sciences BPO market over the forecast period.
Report includes chapters which deeply display the following deliverable about industry :
• Global Life Sciences BPO Market Research Objective and Assumption
• Global Life Sciences BPO Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Global Life Sciences BPO Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Global Life Sciences BPO Market, By Regions
• Global Life Sciences BPO Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Global Life Sciences BPO Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Global Life Sciences BPO Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Global Life Sciences BPO Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key companies covered as a part of this study include Anthelio Healthcare Solutions,
Accenture plc, Cognizant Technology Solutions, Catalent, Inc., Covance, Inc.,
Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International
Corporation and Quintiles Transnational Corporation.
Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-toanalyst/24
Detailed Segmentation:
• Global Life Sciences BPO Market, By Service Type:
• Medical Device Outsourcing
• Pharmaceutical Outsourcing
 CMO
 API Manufacturing
 Final dosage form manufacturing
 Packaging
 CRO
 Drug Discovery
 Preclinical studies
 Early Phase I - IIa
 Phase IIa - III
 Phase IIIb - IV
 Medical coding and writing
 Monitoring
 Clinical Data Management
 Bio-statistics
 Site management
 Protocol development
• Regulatory Information
• Global Life Sciences BPO Market, By End User:
• Healthcare Providers
• Healthcare Payers
• Global Life Sciences BPO Market, By Geography:
• North America
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

The Internet of Thing (IoT) is a technology embedded with software, sensors, actuators, electronics and network connectivity through which data can be collected and exchanged.